Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Mejia-Hernandez JO, Raghu D, Caramia F, Clemons N, Fujihara K, Riseborough T, Teunisse A, Jochemsen AG, Abrahmsen L, Blandino G, Russo A, Gamell C, Fox SB, Mitchell C, Takano EA, Byrne D, Miranda PJ, Saleh R, Thorne H, Sandhu S, Williams SG, Keam SP, Haupt Y, Haupt S
Cancers (Basel). 2022 Aug 16;14(16):3947. doi: 10.3390/cancers14163947.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.